Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2017

10.01.2017 | Original Article

Etiologic spectrum and functional outcome of the acute inflammatory myelitis

verfasst von: Edgar Carnero Contentti, Javier Pablo Hryb, Ana Diego, José Luis Di Pace, Mónica Perassolo

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Clinical, neuroimaging, and laboratory features are not specific enough to establish the etiological diagnosis of the acute inflammatory myelitis (AIM). Longitudinally extensive transverse myelitis (LETM) seen on magnetic resonance imaging (MRI) has been associated with a poor functional prognosis. The aim of this study was to assess the functional outcomes of a first AIM event comparing patients with LETM vs. no LETM on MRI and to report the differential diagnosis. Clinical, radiological, biochemical aspects were collected, and Winner–Hughes Functional Disability Scale (WHFDS) was performed after 3 and 6 months. Centromedullary lesions were associated with LETM, lateral lesions with partial lesion (PL), and brain MRI lesions with multiple sclerosis and acute encephalomyelitis disseminated. LETM patients were associated with a worse functional outcome as the need of a wheelchair after 3 and 6 months (OR = 7.61 p = 0.01; OR 4.8 p = 0.04, respectively), a walker or cane (OR = 11.0 p = 0.002, OR = 4.3 p = 0.03, respectively). In addition, we found a correlation between LETM and acute complete transverse myelitis and PL with acute partial transverse myelitis (83.3 and 90.9%, respectively; p < 0.0001). In conclusion, AIM is a heterogeneous syndrome from an etiological point of view and LETM patients had worse functional prognosis compared with PL after 3 and 6 months.
Literatur
1.
Zurück zum Zitat Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis Optica. Lancet Neurol 6:805–815CrossRefPubMed Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis Optica. Lancet Neurol 6:805–815CrossRefPubMed
2.
Zurück zum Zitat Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS et al (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157–1174CrossRefPubMedPubMedCentral Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS et al (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157–1174CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Transverse Myelitis Consortium Working Group (TMCW) (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505CrossRef Transverse Myelitis Consortium Working Group (TMCW) (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499–505CrossRef
5.
Zurück zum Zitat Scott TF, Frohman EM, De Seze J et al (2011) Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 77(24):2128–2134CrossRefPubMed Scott TF, Frohman EM, De Seze J et al (2011) Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 77(24):2128–2134CrossRefPubMed
6.
Zurück zum Zitat Christensen PB, Wermuth L, Hinge HH, Bomers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 8:431–435 Christensen PB, Wermuth L, Hinge HH, Bomers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 8:431–435
7.
Zurück zum Zitat Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F et al (2010) Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol 67:724–730CrossRefPubMed Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F et al (2010) Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol 67:724–730CrossRefPubMed
8.
Zurück zum Zitat Cobo Calvo A, Mañé Martínez MA, Alentorn-Palau A, Bruna Escuer J, Romero Pinel L, Martínez-Yélamos S (2013) Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol 3(13):135CrossRef Cobo Calvo A, Mañé Martínez MA, Alentorn-Palau A, Bruna Escuer J, Romero Pinel L, Martínez-Yélamos S (2013) Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol 3(13):135CrossRef
9.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed
11.
Zurück zum Zitat Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19(10):1261–1267CrossRefPubMed Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19(10):1261–1267CrossRefPubMed
12.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed
13.
Zurück zum Zitat Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532–535CrossRefPubMed Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532–535CrossRefPubMed
14.
Zurück zum Zitat De Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewiski S et al (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950–1953CrossRefPubMed De Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewiski S et al (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950–1953CrossRefPubMed
15.
Zurück zum Zitat Swanton JK, Fernando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al (2006) Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 77:830–833CrossRefPubMed Swanton JK, Fernando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al (2006) Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 77:830–833CrossRefPubMed
16.
Zurück zum Zitat Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6:677–686CrossRefPubMed Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6:677–686CrossRefPubMed
17.
Zurück zum Zitat Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1–9CrossRef Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1–9CrossRef
18.
Zurück zum Zitat Wingerchuk DM, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:1–13CrossRef Wingerchuk DM, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:1–13CrossRef
19.
Zurück zum Zitat Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed
20.
Zurück zum Zitat Sepúlveda M, Blanco Y, Rovira A, Rio J, Mendibe M, Llufriu S et al (2013) Analysis of prognostic factors associated with longitudinally extensive transverse myelitis. Mult Scler 19(6):742–748CrossRefPubMed Sepúlveda M, Blanco Y, Rovira A, Rio J, Mendibe M, Llufriu S et al (2013) Analysis of prognostic factors associated with longitudinally extensive transverse myelitis. Mult Scler 19(6):742–748CrossRefPubMed
21.
Zurück zum Zitat Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C et al (2010) Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 74:737–742CrossRef Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C et al (2010) Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 74:737–742CrossRef
22.
Zurück zum Zitat Costa C, Arrambide G, Tintore M, Castilló J, Sastre-Garriga J, Tur C et al (2012) Value of NMO-IgG determination at the time of presentation as CIS. Neurology 78(20):1608–1611CrossRefPubMed Costa C, Arrambide G, Tintore M, Castilló J, Sastre-Garriga J, Tur C et al (2012) Value of NMO-IgG determination at the time of presentation as CIS. Neurology 78(20):1608–1611CrossRefPubMed
23.
Zurück zum Zitat Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al (2006) Neuromyelitis óptica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566–569CrossRefPubMed Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al (2006) Neuromyelitis óptica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566–569CrossRefPubMed
24.
Zurück zum Zitat Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A et al (2015) Short Myelitis Lesions in Aquaporin-4-IgG—positive neuromyelitis optica spectrum disorders. JAMA Neurol 72(1):81–87CrossRefPubMedPubMedCentral Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A et al (2015) Short Myelitis Lesions in Aquaporin-4-IgG—positive neuromyelitis optica spectrum disorders. JAMA Neurol 72(1):81–87CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Harzheim M (2004) Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 217:217–223CrossRefPubMed Harzheim M (2004) Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 217:217–223CrossRefPubMed
26.
27.
Zurück zum Zitat Scott TF, Kassab SL, Singh S (2005) Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 11:373–377CrossRefPubMed Scott TF, Kassab SL, Singh S (2005) Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 11:373–377CrossRefPubMed
28.
Zurück zum Zitat Ropper AH, Poskanzer DC (1978) The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 4:51–59CrossRefPubMed Ropper AH, Poskanzer DC (1978) The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 4:51–59CrossRefPubMed
29.
Zurück zum Zitat Ruiz-Gaviria R, Baracaldo I, Castañeda C et al (2015) Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: a meta-analysis. Mult Scler Relat Disord. 4(4):345CrossRefPubMed Ruiz-Gaviria R, Baracaldo I, Castañeda C et al (2015) Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: a meta-analysis. Mult Scler Relat Disord. 4(4):345CrossRefPubMed
Metadaten
Titel
Etiologic spectrum and functional outcome of the acute inflammatory myelitis
verfasst von
Edgar Carnero Contentti
Javier Pablo Hryb
Ana Diego
José Luis Di Pace
Mónica Perassolo
Publikationsdatum
10.01.2017
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2017
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-016-0742-y

Weitere Artikel der Ausgabe 2/2017

Acta Neurologica Belgica 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.